Ampio Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Ampio Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Ampio Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $161K, a 66.6% decline year-over-year.
  • Ampio Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $942K, a 84.3% decline year-over-year.
  • Ampio Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $942K, a 84.3% decline from 2022.
  • Ampio Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $5.98M, a 71.1% increase from 2021.
  • Ampio Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $3.5M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.